# BON Unveils Joint Lab for Natural Ingredients & Biomanufacturing with China Oat Group, Advancing Life Sciences Innovation

- Link: https://www.thailand-business-news.com/pr-news/bon-unveils-joint-lab-for-natural-ingredients-biomanufacturing-with-china-oat-group-advancing-life-sciences-innovation
- Published: 2026-11-21T04:30:00+07:00
- Author: PR Newswire

XIAN, China, Nov. 21, 2026 /PRNewswire/ — Bon Natural Life Limited (NASDAQ: BON)("
BON" or the "Company"), a leading provider of bio-ingredient solutions for the natural,
health, and personal care industries, today announced that its subsidiary, Xi’an
App-Chem Bio (Tech) Co., Ltd. ("App-Chem") recently convened a symposium with China
Oat Group Co., Ltd. ("China Oat Group") on the theme of "Advancing the High-Quality
Development of China’s Health Industry". At the event, the two parties announced
the establishment of the BON Natural Ingredients and Biomanufacturing Joint Laboratory(
the "BON Joint Lab" or the "Joint Lab").

Through an innovative collaboration model, the BON Joint Lab aims to build an integrated
innovation framework spanning the entire value chain, from fundamental research 
and pilot-scale development to standard-setting and industrial commercialization.
The Joint Lab will focus on developing an AI-driven technological platform for the
biomanufacturing of natural ingredients, with synthetic biology serving as its technological
foundation and artificial intelligence (AI) as a key competitive differentiator.
Its primary focus will be the development of biomanufacturing technologies for high-
value natural ingredients. This integrated technological framework is expected to
enhance the Joint Lab’s competitive position in the natural ingredients biomanufacturing
sector while offering the industry new alternatives to conventional production methods.

Oats are widely recognized for their nutritional value and health benefits. They
contain bioactive compounds such as beta-glucan and avenanthramides (AVAs), which
have demonstrated various biological activities, including cardiovascular protection,
blood glucose regulation, antioxidant effects, and anti-inflammatory properties.
As a supplier of oat-based health products, China Oat Group serves a market characterized
by strong demand and significant growth potential. However, limited availability
of natural raw materials and high sourcing costs have constrained the broader commercial
application and market expansion of oat-derived products.

Through the establishment of the Joint Lab, BON and China Oat Group aim to develop
biomanufacturing technologies for oat-derived natural ingredients, with the goal
of fundamentally addressing challenges related to supply availability, supply stability,
and high production costs. BON and China Oat Group believe that this initiative 
is of significant importance in expanding the market for oat-derived natural ingredients.

Standards development plays a critical role in the biomanufacturing of natural ingredients.
The unique complexity of natural ingredient sourcing, heightened regulatory scrutiny
of product safety, and distinct consumer preferences for naturally derived ingredients
make the establishment of standards for biomanufactured natural ingredients critically
important to their commercial value.

BON and China Oat Group have undertaken extensive and productive work in developing
quality standards for natural ingredients. The Joint Lab will make standards development
a dedicated area of focus, conducting systematic testing and validation of key parameters,
including ingredient purity, safety, and elemental and isotopic profiles. Through
a comprehensive and integrated process of evaluation and optimization, the Joint
Lab aims to establish systematic differentiation in product standards across multiple
dimensions, including safety, differentiated quality standards, and similarity to
naturally derived counterparts.

BON has established a strong presence in the natural ingredients biomanufacturing
sector and has articulated its vision of becoming an "AI-driven pioneer in digital
nutrition". The Company is committed to accelerating the transition from conventional
natural extraction methods to AI-driven biomanufacturing. The Company believes that
it has built a strong technological foundation in natural products, biosynthesis,
and the application of AI in biology, supported by robust industrialization capabilities
and global market development expertise.

China Oat Group has developed extensive expertise across the entire oat value chain
and holds more than ten invention patents in China, along with multiple patents 
in the United States, Europe, Canada, Australia, and other markets. Leveraging its
advanced technologies in areas such as oat protein enzymatic hydrolysis and the 
preservation of beta-glucan bioactivity, China Oat Group has developed a portfolio
of oat-based nutritional products whose health benefits have been evaluated through
medical research. China Oat Group was also among the first companies to achieve 
large-scale, standardized deep processing of oats, with its related technologies
receiving authoritative certifications in Europe and the United States.

Mr. Yongwei Hu, Chairman of BON, commented, "Our strategic collaboration with China
Oat Group marks a pivotal step in our efforts to establish a stronger presence in
the core natural ingredients sector, accelerate our expansion into the rapidly growing
global biomanufacturing market, and further strengthen our position as an innovation
leader in the industry. Through the Joint Lab, we aim to advance cutting-edge research
in areas such as the biosynthesis of high-value natural ingredients, the discovery
of functional bioactive compounds, and precision nutrition interventions. We are
committed to accelerating the commercialization of scientific and technological 
innovations and delivering a broader range of safe and effective health solutions
to consumers. Through the disciplined execution of our technology-driven business
strategy, we seek to unlock significant commercial value and generate sustainable
returns for our investors."

**About Bon Natural Life Limited ("BON")**

BON is a Cayman Islands company engaged in the business of natural, health, and 
personal care industries. For more information, please visit the Company’s website
at [http://www.bnlus.com](http://www.bnlus.com).

For more information, please contact:
Cindy Liu | IREmail: [bonnatural@appchem.cn](https://www.thailand-business-news.com/pr-news/bonnatural@appchem.cn)

**Safe Harbor Statement**

This press release contains certain statements that may include "forward-looking
statements." All statements other than statements of historical fact included herein
are "forward-looking statements." These forward-looking statements are often identified
by the use of forward-looking terminology such as "believes," "expects" or similar
expressions, involve known and unknown risks and uncertainties. Although the Company
believes that the expectations reflected in such forward-looking statements are 
reasonable, they do involve assumptions, risks, and uncertainties, and these expectations
may prove to be incorrect. You should not place undue reliance on these forward-
looking statements, which speak only as of the date of this press release. The Company’s
actual results could differ materially from those anticipated in these forward-looking
statements as a result of a variety of factors, including those discussed in the
Company’s periodic reports that are filed with the Securities and Exchange Commission
and available on its website ([http://www.sec.gov](http://www.sec.gov)). All forward-
looking statements attributable to the Company or persons acting on its behalf are
expressly qualified in their entirety by these factors. Other than as required under
the securities laws, the Company does not assume a duty to update these forward-
looking statements.

 

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [BON Unveils Joint Lab for Natural Ingredients & Biomanufacturing with China Oat Group, Advancing Life Sciences Innovation ](https://en.prnasia.com/story/archive/5103285_CN03285_0?rand=184833)
